Level 2 · Controlled trialRandomised controlled trial

Hepatoprotective effect of combination of L-carnitine and magnesium-hydroxide in nonalcoholic fatty liver disease patients: a double-blinded randomized controlled pilot study

Hazzan R, Abu Ahmad N, Slim W, Mazen E, Neeman Z

European review for medical and pharmacological sciences · 1 October 2022

AUTHORS’ ABSTRACT

The abstract of this article is not reproduced here: its licence does not allow it. It can be read freely on the journal’s website or on Europe PMC.

Scientific information content; it does not replace the advice of a healthcare professional. The presence of a study in this library does not constitute a claim about our products.

← All studies